Immunocytochemistry on circulating tumor cells (CTCs) is an essential technique for the study of cancers and their progression. Using specific antibodies, this method allows the detection and localization of specific cellular markers, thus providing valuable insight into the nature and behavior of CTCs. It also allows the counting of CTCs, providing essential quantitative information for assessing their abundance and metastatic potential.
Immunocytochimie MCF7 ck epcam3
This bright field technique allows, in addition to the morphological analysis of the cells, to study the expression of certain specific markers associated with CTCs.
Blood sample
< 4 hours
Cells fixed and analyzed on the isolation support
Cytological
staining
Immunofluorescence
Immunocytochemistry
Fluorescence in situ hybridization
Blood sample
< 3 days
Cytological
staining
Immunofluorescence
Immunocytochemistry
Fluorescence in situ hybridization
Blood sample
< 3 days
ou
Cells fixed detached
from the isolation support for analysis in suspension or on slide
Cytological
staining
Immunofluorescence
Immunocytochemistry
Fluorescence in situ hybridization
Blood sample
< 4 hours
ou
Cells fixed detached
from the isolation support for analysis in suspension or on slide
Cytological
staining
Immunofluorescence
Immunocytochemistry
Fluorescence in situ hybridization
Blood sample
< 4 hours
Living cells detached
from the isolation support for suspension analysis
Cytological
staining
Immunofluorescence
Immunocytochemistry
Fluorescence in situ hybridization
Blood sample < 3 days
or
Fixed cells detached
from the isolation support for analysis in suspension or on slide
Blood sample < 4 hours
or
Fixed cells detached
from the isolation support for analysis in suspension or on slide
ScreenCell compatible kits for immunocytochemistry on circulating tumor cells (CTCs), guarantee quality results thanks to a high recovery rate of CTCs and precise detection of biological markers using our pre-established protocols.
You’ve come to the right place!
Fill in the fields below and we’ll take care of the rest.
